These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15209926)

  • 1. How useful is quantitative risk assessment?
    Apostolakis GE
    Risk Anal; 2004 Jun; 24(3):515-20. PubMed ID: 15209926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does concern-driven risk management provide a viable alternative to QRA?
    Cox LA
    Risk Anal; 2007 Feb; 27(1):27-43. PubMed ID: 17362398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk management of third parties during construction in multifunctional urban locations.
    Suddle S
    Risk Anal; 2009 Jul; 29(7):1024-40. PubMed ID: 19302276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of advances in technology for maritime risk assessment.
    Wang J; Sii HS; Yang JB; Pillay A; Yu D; Liu J; Maistralis E; A Saajedi
    Risk Anal; 2004 Aug; 24(4):1041-63. PubMed ID: 15357827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods and practices used in incident analysis in the Finnish nuclear power industry.
    Suksi S
    J Hazard Mater; 2004 Jul; 111(1-3):73-9. PubMed ID: 15231350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative risk assessment modeling for nonhomogeneous urban road tunnels.
    Meng Q; Qu X; Wang X; Yuanita V; Wong SC
    Risk Anal; 2011 Mar; 31(3):382-403. PubMed ID: 21029142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian ranking of sites for engineering safety improvements: decision parameter, treatability concept, statistical criterion, and spatial dependence.
    Miaou SP; Song JJ
    Accid Anal Prev; 2005 Jul; 37(4):699-720. PubMed ID: 15949462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk criteria for assessment of temporary changes in a nuclear power plant.
    Cepin M
    Risk Anal; 2007 Aug; 27(4):991-8. PubMed ID: 17958506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncertainty analysis based on probability bounds (p-box) approach in probabilistic safety assessment.
    Karanki DR; Kushwaha HS; Verma AK; Ajit S
    Risk Anal; 2009 May; 29(5):662-75. PubMed ID: 19302279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the strengths and weaknesses of quantitative methods used in health impact assessment.
    O'Connell E; Hurley F
    Public Health; 2009 Apr; 123(4):306-10. PubMed ID: 19324380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of the dermal sensitization Quantitative Risk Assessment (QRA) for fragrance ingredients.
    Api AM; Vey M
    Regul Toxicol Pharmacol; 2008 Oct; 52(1):53-61. PubMed ID: 18635300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the ecological risk assessment process.
    Dale VH; Biddinger GR; Newman MC; Oris JT; Suter GW; Thompson T; Armitage TM; Meyer JL; Allen-King RM; Burton GA; Chapman PM; Conquest LL; Fernandez IJ; Landis WG; Master LL; Mitsch WJ; Mueller TC; Rabeni CF; Rodewald AD; Sanders JG; van Heerden IL
    Integr Environ Assess Manag; 2008 Jul; 4(3):306-13. PubMed ID: 18324871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified risk graph method using fuzzy rule-based approach.
    Nait-Said R; Zidani F; Ouzraoui N
    J Hazard Mater; 2009 May; 164(2-3):651-8. PubMed ID: 18835093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients.
    Api AM; Basketter DA; Cadby PA; Cano MF; Ellis G; Gerberick GF; Griem P; McNamee PM; Ryan CA; Safford R
    Regul Toxicol Pharmacol; 2008 Oct; 52(1):3-23. PubMed ID: 18406028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra.
    Claxton K; Sculpher M; McCabe C; Briggs A; Akehurst R; Buxton M; Brazier J; O'Hagan T
    Health Econ; 2005 Apr; 14(4):339-47. PubMed ID: 15736142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.